Molecular Partners Ag (MOLN) Interest Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Interest Expenses of -$14.05 for Q1 2026, up 98.88% year-on-year from -$7.06 in Q1 2025, and down 100.0% on a QoQ basis from $6.3 million in Q4 2025.

Molecular Partners Ag (MOLN) Interest Expenses (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Interest Expenses for 7 consecutive years, with -$14.05 the latest figure, recorded in Q1 2026.

  • Quarterly Interest Expenses rose 98.88% year-over-year to -$14.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 17733.36% YoY) and the FY2025 annual result came in at $6.3 million, up 14457.33% from the prior year.
  • Interest Expenses eased to -$14.05 in Q1 2026 per MOLN's latest filing, from $6.3 million in the prior quarter.
  • Over the last five years, Interest Expenses for MOLN reached as high as $6.3 million in Q4 2025 and fell as low as -$1.3 million in Q2 2023.
  • A 5-year average of $910682.9 and a median of -$12.45 in 2023 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2024 — Interest Expenses sank 23375.85% — and 2025, when it jumped 21145.8%.
  • Year by year, Interest Expenses stood at $643111.7 in 2022, then jumped by 803.81% to $5.8 million in 2023, then sank by 99.25% to $43399.5 in 2024, then surged by 14450.09% to $6.3 million in 2025, then plunged by 100.0% to -$14.05 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered -$14.05, $6.3 million, and -$196.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - -14.05

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.05
Mar 31, 2026 -14.05
Dec 31, 2025 6.31 Mn
Dec 31, 2025 6.31 Mn
Sep 30, 2025 -196.27
Sep 30, 2025 -196.27
Jun 30, 2025 4.23 Mn
Jun 30, 2025 4.23 Mn
Mar 31, 2025 -1,259.07
Mar 31, 2025 -1,259.07
Dec 31, 2024 43,399.52
Dec 31, 2024 43,399.52
Sep 30, 2024 -2,923.61
Sep 30, 2024 -2,923.61
Jun 30, 2024 19,904.28
Jun 30, 2024 19,904.28
Mar 31, 2024 -11.46
Mar 31, 2024 -11.46
Dec 31, 2023 5.81 Mn
Dec 31, 2023 5.81 Mn